Who are we?
Mithra Pharmaceuticals SA, founded in 1999 as a spin-off of the University of Liège by Mr. François Fornieri and Prof. Dr. Jean-Michel Foidart, is a pharmaceutical company focused in women’s health. Mithra’s mission is to support and improve women’s overall quality of life. As such the company aspires to become a worldwide leader in women’s health by developing, manufacturing and commercialising proprietary, innovative and differentiated drugs and other complex therapeutic entities in four fields of women’s health, fertility and contraception, menopause and osteoporosis, vaginal infections and cancers.
Mithra has a total headcount of approximately 85 staff members and is headquartered in Liège, Belgium. Further information can be found at: www.mithra.com
Why do we commit ourselves to CRBP?
Dedicated to Women’s’ health, Mithra is committed to act as a socially responsible actor in the community since its very foundation. While promoting innovation in women’s health Mithra embraced the issue of greater access to medicines since its beginning, ensuring its products remain affordable to all and especially to the more vulnerable younger female population.
Whereas Innovation is a key driver of Mithra’s development, affordability is an essential element to guarantee the widest access possible to patients and especially to the younger female population.
What do we for CRBP?
Sharing our pragmatic approach to improve children’s rights within our local community and learn from our peers to improve what we all do as companies for children is key. As a member of the Children’s Rights and Business Principle workgroup we will promote CRBPs further across the nationwide business community to improve the reach of CRBP and develop its sustainability.
Letter of Commitment